Johnson Deferred Long Term Liab from 2010 to 2024
| JNJ Stock | USD 155.01 0.39 0.25% |
Deferred Long Term Liabilities | First Reported 2009-06-30 | Previous Quarter 6.4 B | Current Value 4.4 B | Quarterly Volatility 2.2 B |
Check Johnson Johnson financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Johnson Johnson's main balance sheet or income statement drivers, such as Depreciation And Amortization of 7.9 B, Interest Expense of 1.3 B or Total Revenue of 49.3 B, as well as many indicators such as Price To Sales Ratio of 2.83, Dividend Yield of 0.0177 or PTB Ratio of 5.86. Johnson financial statements analysis is a perfect complement when working with Johnson Johnson Valuation or Volatility modules.
Johnson | Deferred Long Term Liab |
Latest Johnson Johnson's Deferred Long Term Liab Growth Pattern
Below is the plot of the Deferred Long Term Liab of Johnson Johnson over the last few years. It is liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue. Johnson Johnson's Deferred Long Term Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Johnson Johnson's overall financial position and show how it may be relating to other accounts over time.
| Deferred Long Term Liab | 10 Years Trend |
|
Deferred Long Term Liab |
| Timeline |
Johnson Deferred Long Term Liab Regression Statistics
| Arithmetic Mean | 4,945,863,333 | |
| Geometric Mean | 4,331,357,411 | |
| Coefficient Of Variation | 47.77 | |
| Mean Deviation | 2,086,139,111 | |
| Median | 4,975,850,000 | |
| Standard Deviation | 2,362,597,021 | |
| Sample Variance | 5581864.7T | |
| Range | 6.9B | |
| R-Value | 0.76 | |
| Mean Square Error | 2577777.9T | |
| R-Squared | 0.57 | |
| Significance | 0 | |
| Slope | 399,262,679 | |
| Total Sum of Squares | 78146105.6T |
Johnson Deferred Long Term Liab History
About Johnson Johnson Financial Statements
Investors use fundamental indicators, such as Johnson Johnson's Deferred Long Term Liab, to determine how well the company is positioned to perform in the future. Although Johnson Johnson's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
| Last Reported | Projected for Next Year | ||
| Deferred Long Term Liabilities | 7.3 B | 5 B |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of Johnson Johnson Correlation against competitors. For more information on how to buy Johnson Stock please use our How to buy in Johnson Stock guide.You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Johnson Johnson. If investors know Johnson will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Johnson Johnson listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.89) | Dividend Share 4.86 | Earnings Share 6.05 | Revenue Per Share 36.428 | Quarterly Revenue Growth 0.052 |
The market value of Johnson Johnson is measured differently than its book value, which is the value of Johnson that is recorded on the company's balance sheet. Investors also form their own opinion of Johnson Johnson's value that differs from its market value or its book value, called intrinsic value, which is Johnson Johnson's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Johnson Johnson's market value can be influenced by many factors that don't directly affect Johnson Johnson's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Johnson Johnson's value and its price as these two are different measures arrived at by different means. Investors typically determine if Johnson Johnson is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Johnson Johnson's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.